Troxerutin-Mediated Complement Pathway Inhibition is a Disease-Modifying Treatment for Inflammatory Arthritis.
Sahu D, Bishwal SC, Malik MZ, Sahu S, Kaushik SR, Sharma S, Saini E, Arya R, Rastogi A, Sharma S, Sen S, Singh RKB, Liu CJ, Nanda RK, Panda AK.
Sahu D, et al. Among authors: malik mz.
Front Cell Dev Biol. 2022 Mar 31;10:845457. doi: 10.3389/fcell.2022.845457. eCollection 2022.
Front Cell Dev Biol. 2022.
PMID: 35433699
Free PMC article.